Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measurement of PD-L1 Expression in Cancer to Monitor Treatment Response.

NCT04436406 is registered in ClinicalTrials.gov with Guy's and St Thomas' NHS Foundation Trust as lead sponsor.

NCT NCT04436406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04436406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measurement of PD-L1 Expression in Cancer to Monitor Treatment Response.
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
March 11, 2020
Completion date
January 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non-small cell lung cancer